List view / Grid view

David Enloe

 

news

Avalanche and Lonza announce global manufacturing collaboration for AAV vectors for gene therapy

Avalanche Biotechnologies, Inc., a leader in the area of long-term…

16 May 2012 | By

Avalanche Biotechnologies, Inc., a leader in the area of long-term protein delivery for ocular diseases, and Lonza, a global leader in the field of biologics manufacturing, today announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy.